Clinical trial
Simplification of CF-related Diabetes Screening by the Use of a Home-based Oral Glucose Tolerance Test (OGTT): A Pilot Study to Evaluate the Validity and Patients' Perceptions
NCT03227094 is registered in ClinicalTrials.gov with Institut de Recherches Cliniques de Montreal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Simplification of CF-related Diabetes Screening by the Use of a Home-based Oral Glucose Tolerance Test (OGTT): A Pilot Study to Evaluate the Validity and Patients' Perceptions
- Lead sponsor
- Institut de Recherches Cliniques de Montreal
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 13, 2017
- Completion date
- April 1, 2020
- Enrollment
- 37 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis, cystic fibrosis-related diabetes